ライフサイエンスコーパス: serology

1 eriprosthetic tissue and synovial fluid (and serology).

2 negative pretransplant HBc, HCV, EBV, or CMV serology.

3 Post-mortem blood was tested by serology.

4 y anaemia and was comparable to conventional serology.

5 his method was compared with standard 2-tier serology.

6 he positive predictive value of Lyme disease serology.

7 that for Tanzanian volunteers with negative serology.

8 milar levels of B-cell memory independent of serology.

9 173 (95%) of 182 children with dual-positive serology.

10 ported myositis, and negative trichinellosis serology.

11 or WNV infection by nucleic acid testing and serology.

12 seroresponses were determined with multiplex serology.

13 hailand, and positive anti-hepatitis C virus serology.

14 that the population is 95% positive for EBV serology.

15 by serology only, and in 22 by both qPCR and serology.

16 with normal mucosa (Marsh 0) but positive CD serology.

17 lture and/or more sensitive measures such as serology.

18 at 0, 6, 9, and 12 months of age by PCR and serology.

19 -PCR) assays in addition to cell culture and serology.

20 compared to patients with no LB and negative serology.

21 polymerase chain reaction, virus culture, or serology.

22 onduction disorder), and hepatitis B and HIV serology.

23 time-consuming and potentially inconclusive serology.

24 ) tested positive by RT-PCR and 62 (3.1%) by serology.

25 0.86 infections per child-year by stool and serology.

26 ith acute wheezing were analyzed by means of serology.

27 104 samples) for anti-phenolic glycolipid I serology.

28 evidenced by assessment of culture, PCR, and serology.

29 ated with survival in the oropharynx (HR for serology, 0.16; 95% CI, 0.03-0.47; for p16 measures, 0.1

30 ering all head and neck cancer cases (HR for serology,0.49; 95% CI, 0.23-1.04; for p16, 0.65; 95% CI,

31 regular (18)F-FDG PET scans and specific AE serology, 11 (25%) presented pathologic (18)F-FDG uptake

32 in patients with no clinical LB and positive serology (15.3%), higher in patients with clinical LB wi

33 the cohort had positive Helicobacter pylori serology (16 vs 2 in the CG, P = .003).

34 By serology, 16 of 121 children (13.2%) had acute HBoV1 inf

35 with clinical LB with positive and negative serology (19.3% and 20.9% respectively), and highest in

36 in patients with no clinical LB and negative serology (29.3%).

37 Finally, a negative HI serology 4 days after the onset of influenza symptoms pr

38 Prometheus IBD Serology 7 may be useful in the evaluation of selected p

39 for immunologic markers using Prometheus IBD Serology 7.

40 y-positive participants, 22 were positive by serology (95.7% sensitivity) and 21 were positive by the

41 Applying detailed serology, advanced FACS analysis, and systems biology, w

42 ntaining amyloid fibrils induced antinuclear serology against a panel of self-antigens.

43 HIV serology, age, nutritional status, smoking, alcohol inta

44 e, race, disease location, and antimicrobial serologies and provided a sensitivity of 66% (95% CI 51-

45 es are frequent in women with brain-reactive serology and a child with ASD.

46 dies from blood of women with brain-reactive serology and a child with ASD.

47 Cohort children underwent pre-/postseason serology and active school absence-based surveillance to

48 s population easily identifiable by maternal serology and amenable to prevention messages.

49 e setting for further evaluation by standard serology and biopsy.

50 as evolved from phenotypic analysis, such as serology and biotypes, to much-more-robust molecular gen

51 ral infections were monitored clinically, by serology and blood DNA polymerase chain reaction.

52 ase was established applying celiac-specific serology and duodenal histology, while one case was reve

53 containing HEV were characterised by use of serology and genomic phylogeny.

54 H. pylori was assessed using both multiplex serology and H. pylori IgG ELISA.

55 Strain-specific serology and HLA alloantibody production was determined

56 B. mandrillaris serology and immunohistochemistry for free-living amoeba

57 of infection with an EBV-like virus based on serology and infant histopathology similar to pulmonary

58 ll-bowel mucosal villous height:crypt depth, serology and laboratory test results, gastrointestinal s

59 8) may provide clues to their phenotypes and serology and may suggest protocols for prevention and tr

60 A combination of HBoV1 serology and nasopharyngeal DNA quantitative PCR and mRN

61 tiplex PCR from case patients, and serum for serology and nasopharyngeal swab specimens for multiplex

62 In a subset of 162 patients with both HPV serology and p16 immunohistochemical (IHC) measures avai

63 Serology and PCR also suggested the presence of a henipa

64 often by PCR testing of other body fluids or serology and plaque-reduction neutralization testing.

65 Consecutive OT patients with positive serum serology and positive western blot (WB) on ocular sample

66 Women provided data and blood for serology and quantitative polymerase chain reaction (PCR

67 should be screened pretransplantation by HEV serology and RNA.

68 view, and laboratory testing including mumps serology and RT-PCR.

69 mples, along with anti-phenolic glycolipid I serology and skin tests from the same individual, from 1

70 ectively) were similar to the combination of serology and ST (83.0% and 95.6%, respectively).

71 Agreement with the combination of serology and ST was moderate (84% concordance; kappa = 0

72 Serology and ST were performed in all individuals.

73 ar performance and practical advantages over serology and ST.

74 Our aim was to compare this test to serology and ST.

75 ctions by 8 pathogens were assessed by using serology and stool examination.

76 Infections with pathogens were assessed by serology and stool examinations.

77 In conclusion, the combined serology and tumor DNA results suggest that beta HPV typ

78 regarding presence of H. pylori infection by serology and urea breath test (UBT).

79 and/or the presence of a concordant positive serology and urine POC-CCA test, which we consider to be

80 The combination of serology and urine POC-CCA testing detected all 23 micro

81 By combining serology and viral load quantitation, we identified 4 ac

82 pathogen Coxiella burnetii, relies mainly on serology and, in prevaccination assessment, on skin test

83 After excluding subjects with equivocal serology and/or borderline ST results, IFN-gamma product

84 ory T cells with biomarkers of inflammation, serologies, and subclinical atherosclerosis in 912 parti

85 tive protein, tuberculin skin test, syphilis serology, and chest radiograph) followed by more complex

86 n and the relationship between EBV load, EBV serology, and EBV-related morbidity (posttransplant lymp

87 ent information on virus molecular genetics, serology, and host reactivity.

88 hemia time, renal function, donor Toxoplasma serology, and maintenance immunosuppression.

89 of HSV, including light microscopy, culture, serology, and nucleic acid-based tests.

90 detailed dermatological assessment, syphilis serology, and PCR on lesional swabs to detect the presen

91 amples prepared by sedimentation technique], serology, and point-of-care circulating cathodic antigen

92 ly asked questions focusing on transmission, serology, and policy/legal issues surrounding patient ca

93 ) tested positive by RT-PCR and 92 (4.6%) by serology; and for AdV, 111 (5.5%) tested positive by RT-

94 e association between 15 different multiplex serology antigens and the risk of gastric cardia (GCA) a

95 T-qPCR in multiple diagnostic specimens, and serology are essential to ensure an accurate diagnosis o

96 review includes birth order and maternal HBV serology as proxies for age at infection.

97 1, 33, 35, 45, 52, and 58) using a multiplex serology assay.

98 month by microscopy, PCR and immunoblot, and serology at 6 and 9 months.

99 (TESA)-blots at birth and 1 month and by IgG serology at 6 and 9 months.

100 Interpretation of Toxoplasma serology at a reference laboratory can help differentiat

101 Positive P. falciparum serology at baseline was associated with a lower parasit

102 M, 123 IDU, and 3078 HET with a negative HCV serology at baseline.

103 12 of 16 patients tested had positive HHV-8 serology at diagnosis.

104 Measles detection in CSF was performed by serology at the California Department of Public Health o

105 Group 1: pre-endoscopy serology availability was retrospectively analysed in a

106 directed serological testing (i.e., Q fever serology, Bartonella serology) in culture-negative cases

107 ys, including in situ hybridization, PCR and serology based on recombinant proteins.

108 Here we used a versatile serology-based approach to determine the natural host of

109 We propose that an individualized serology-based approach to MN, used to complement and re

110 -tiered testing using commercially available serology-based assays is dependent on the stage of infec

111 Thus, existing 2-tier serology-based assays yield low sensitivities (29%-40%)

112 ompared four diagnostic approaches including serology-based biochemical test, PCR assay, microarray a

113 e laboratory confirmation of Lyme disease is serology-based diagnostics.

114 it is possible to assess HPV infection using serology-based methods; however, the suitability of this

115 The replacement of traditional serology-based typing of Escherichia coli by WGS is supp

116 tivity and T-cell activation by means of IgE serology, basophil activation testing, T-cell proliferat

117 immune complex dissociation, influenza ELISA serology became strongly positive in the bronchoalveolar

118 he diagnosis of CD was based on IgG anti-tTG serology, biopsy results and patient follow-up.

119 Faecal calprotectin, thyroid tests, celiac serology, breath tests were more frequently suggested in

120 atient was confirmed as having positive Lyme serology by reference laboratory testing, and there was

121 Serology can be a helpful adjunct to RT-PCR for research

122 In conclusion, positive P. falciparum lysate serology can be used to identify individuals with better

123 Early negative A(H1N1) 2009 HI serology can predict death from influenza.

124 coring systems with a focus on radiology and serology capture most patients who are clinically felt t

125 Reactive syphilis serology caused by latent yaws can occur in ulcers with

126 The clinical significance of discordant serology (CIA(+)/RPR(-)) for maternal and neonatal outco

127 h celiac disease who have been identified by serology, clinical signs, and genetics.

128 tiology, tularemia was diagnosed by advanced serology consisting of two-dimensional Western-immunoblo

129 The human and ferret serology data suggest that a single dose of the vaccine

130 Toxoplasma gondii serology demonstrated exposure.

131 des pneumonia but with negative Coccidioides serology determined by enzyme immunoassay at presentatio

132 Compared with serology, DNA PCR had high clinical sensitivity (100%) b

133 on ventilator, recipient hepatitis C virus + serology, donor age and cold ischemic time.

134 Serology, duodenal histology, comorbidities, response to

135 In this study, serology (ELISA) and molecular techniques (PCR/qPCR) wer

136 eria based on histology, imaging, endoscopy, serology, extrapancreatic organ involvement, and respons

137 Serology findings were negative for celiac disease.

138 for graft failure in patients with positive serology for HCV.

139 reased HCC risk among subjects with positive serology for hepatitis B surface antigen (P for trend =

140 Our subgroup analysis in studies using only serology for HPV detection showed a significant associat

141 ed a possible association with fibroids, and serology for HSV-2 is much more sensitive than self-repo

142 ratory tests, 7 functional scales, reference serology for Lyme disease using Centers for Disease Cont

143 False-positive serology for Lyme disease was reported in patients with

144 Serology for MWPyV VP1 indicates that infection frequent

145 e Control and Prevention criteria, reference serology for other tick-associated pathogens, and cytoki

146 as no difference in distribution of positive serology for other tick-transmitted pathogens or cytokin

147 correlated and the added diagnostic value of serology for respiratory viruses other than influenza vi

148 y immunoblot, with that of standard 2-tiered serology for the diagnosis of Lyme disease.

149 -time reverse transcription-PCR (RT-PCR) and serology for the diagnosis of respiratory syncytial viru

150 e by RT-PCR and 234 (11.6%) were positive by serology; for HMPV, 172 (8.5%) tested positive by RT-PCR

151 tested positive by RT-PCR and 147 (7.3%) by serology; for the PIVs, 94 (4.6%) tested positive by RT-

152 ted numbers of lifetime sex partners and HPV serology from the National Health and Nutrition Examinat

153 d was collected for Helicobacter pylori, HIV serology, gastrin-17, and pepsinogen 1 and 2 concentrati

154 d by bronchoalveolar lavage, lung histology, serology, gene expression in lung tissue, and measuremen

155 Serology has become an increasingly important tool for t

156 Helicobacter pylori antigens using multiplex serology have not been consistent across studies.

157 chieved sustained virologic suppression, HIV serology, HIV-1-specific cell-mediated immune responses

158 HIV serology, HIV-1-specific cell-mediated immune responses,

159 Genotypes, antimicrobial serologies, ileal gene expression, and ileal, rectal, an

160 Serology, immunostaining, and imaging were reviewed and

161 lobulin therapy; prospective analysis of HBV serology in 16 patients commencing intravenous immunoglo

162 transcription polymerase chain reaction and serology in 4 adult populations under surveillance for a

163 eaction (RT-PCR) analysis in 17 cases and by serology in 6 cases.

164 18.4% of participants, and hepatitis C virus serology in 70.3%.

165 performed a cross-sectional analysis of HBV serology in 80 patients established (>6 months) on immun

166 thesis: 1) the availability of pre-endoscopy serology in anaemia; 2) the sensitivities and cost effec

167 This negative serology in fatal cases in young adults reflects the tra

168 International guidelines recommend coeliac serology in iron deficiency anaemia, and duodenal biopsy

169 CIA(+)/RPR(-)/TP-PA(-) serology in pregnancy is likely to be falsely positive.

170 alysis were conducted for anti-H. pylori IgG serology in the Study of Health in Pomerania (SHIP) (rec

171 The false-negative rate of the JCV serology in this study was 37%; therefore, JCV serostatu

172 testing (i.e., Q fever serology, Bartonella serology) in culture-negative cases.

173 t number of positive detections overall, but serology increased diagnostic yield for RSV (by 11.8%),

174 SV infection; and 1 subject without baseline serology information had a new diagnosis of genital HSV.

175 Serology is cross-reactive, laborious, and frequently di

176 Pretransplant CMV serology is currently the only tool for assessing the ri

177 Convalescent-phase serology is impractical, blood culture is slow, and many

178 However, pre-endoscopy serology is often unavailable, thus committing endoscopi

179 d whether the influence of FUT2 on H. pylori serology is part of the mechanisms that underlie these a

180 D with clinical background and extract-based serology is superior to CRD alone in assessing the risk

181 Serology is the mainstay for syphilis diagnosis and trea

182 Serology is the most cost-effective means of detecting b

183 Whilst pathogen serology is typically performed by centralized laborator

184 mended in infants <18 months of age, in whom serology is unreliable.

185 sence of skin ulcers and a reactive syphilis serology, is one major cause, but this infection can be

186 d to Palo Alto Medical Foundation Toxoplasma Serology Laboratory (PAMF-TSL) to determine whether the

187 za Theel, who directs the Infectious Disease Serology Laboratory at the Mayo Clinic, to address why s

188 tic techniques, such as culture, biopsy, and serology, lack rapidity and efficiency.

189 either by whole-cell ELISA test or multiplex serology, likely due to the high prevalence of seroposit

190 Donor age, obesity, alcohol abuse, hepatitis serology, liver only donor, imaging results, and transpl

191 87% correctly, making Cor a 14 the superior serology marker.

192 Using Simoas, serology may be used for the detection of dengue virus i

193 Hence, small-scale serology may serve as the basis for effective adaptive p

194 on polymerase chain reaction (rtRT-PCR), and serology (microneutralization assay).

195 s drug user increased from 12.5% (4/24) with serology negative donors to 70.8% (17/24) if NAT was ava

196 ature correctly classified 77%-95% of the of serology negative Lyme disease patients.

197 tis B (HBV) and hepatitis C (HCV) viruses by serology, no current policy requires the use of nucleic

198 While most isolates exhibited the accepted serology of serotype 35B, one isolate failed to bind to

199 Systems serology of the antibody responses identifies plasma ant

200 t the mutant WciG was nonfunctional, and the serology of the mutant could be restored through complem

201 dy-based vaccine strategies, termed "systems serology", offers an unbiased and comprehensive approach

202 and 2, human herpesvirus 8) using multiplex serology on blood samples collected at birth (cord blood

203 reaction (PCR) on respiratory specimens, and serology on paired sera.

204 cimens by immunofluorescence and PCR, and by serology on paired sera.

205 Trichinella serology on patient sera as well as polymerase chain rea

206 respiratory and environmental specimens, and serology on sera from employees at beginning and end of

207 on four-fold titre rises in strain-specific serology, on average influenza infected 18% (95% CI 16-2

208 radiology only, in 9 by qPCR only, in 17 by serology only, and in 22 by both qPCR and serology.

209 ns; and (3) a finding of HTLV-1 infection by serology or molecular biology.

210 seases that can cause ocular inflammation by serology or molecular diagnostics.

211 dence of the infection in several tissues by serology or polymerase chain reaction.

212 .72-2.10) and normal mucosa with positive CD serology (OR = 1.58; 95% CI = 1.30-1.92).

213 according to the HISORt (Histology, Imaging, Serology, Other organ involvement, Response to therapy)

214 ts for a validation study should be based on serology performed with improved peanut reagents to avoi

215 ce interval, 82.2%-100%), the combination of serology plus urine POC-CCA testing appears to be the mo

216 Among pregnant women with serodiscordant serologies (positive treponemal tests and a negative non

217 The prevalence of reactive combined serology (positive T pallidum haemagglutination test and

218 In both cases, maternal serology prior to termination showed both specific immun

219 s, and assessing treatment response based on serology remains a challenge.

220 ate and another that, based on P. falciparum serology, resembled the malaria-naive Dutch cohort.

221 2 serology results; 22% of participants with serology results had fibroids.

222 w suggests that the frequency of positive H5 serology results is likely to be low; therefore, it is e

223 ng prior to biopsy, and evidence of positive serology results was found in only 5% of patients.

224 nsidering the timing of specimen collection, serology results, patient vaccination status, and time o

225 nts were classified based on clinical LB and serology results.

226 ticipants, 1,658 had blood samples and HSV-2 serology results; 22% of participants with serology resu

227 Complete blood count with differential, serology screen (including cysticercosis and echinococcu

228 All OPOs performed required HIV, HBV and HCV serology screening and 48 (84%) performed confirmatory t

229 Serology screening of total immunoglobulin A in all pati

230 tastases, serum alpha-Fetoprotein, hepatitis serologies, severity of hepatic dysfunction, and presenc

231 All had connective tissue disease (CTD) serologies, spirometry, and high-resolution computed tom

232 Two cases with slightly lower loads, in whom serology suggests the infection may have been caught ear

233 re review of all English-language H5N1 human serology surveys with detailed attention to laboratory m

234 Households were followed up with serology, symptom diaries, and collection of respiratory

235 Follow-up included paired serology, symptom reporting, and polymerase chain reacti

236 a subsample of children with dually positive serology (T1 and T2) to monitor changes in DPP optical d

237 robiological examinations (culture, PCR, and serology) targeted so-called conventional bacterial infe

238 results by both traditional biochemistry and serology (TB&S) and the kmer identification (ID) derived

239 uded numbers of intraepithelial lymphocytes, serology test results (for levels of antibodies against

240 Of 5,126 patients enrolled, RT-PCR and serology test results were available for 2,023, includin

241 Moreover, serology testing based on BASV-G pseudotype neutralizati

242 assay in a laboratory to complement routine serology testing for dengue.

243 rate, rapid, and inexpensive alternatives to serology testing for the screening of HBV infection at f

244 Test program used combined nucleic acid and serology testing to screen for primary infection targeti

245 Annually, syphilis serology testing was done and male circumcision status w

246 H. pylori serology testing was performed by using ELISA.

247 In patients where celiac serology testing was performed, the results were a good

248 Serology tests for HBV were performed from 2007 to 2009,

249 es reported patients' symptoms, results from serology tests, and findings from histologic analyses.

250 negative delayed (18)F-FDG PET and negative serology, the treatment was safely interrupted with no e

251 used an integrative approach termed Systems Serology to analyze relationships among humoral response

252 ntibody test by comparing the results of JCV serology to JCV viruria and viremia in 67 patients enrol

253 We found a strong correlation among positive serology to recombinant proteins LinB-13, 26, 15, 21 and

254 in lung cancer through an analysis involving serology, tumor DNA, RNA, and p16 protein expression.

255 rthern California with discordant treponemal serology underwent reflexive testing with Treponema pall

256 stematic pathogen testing included cultures, serology, urine antigen tests, and molecular detection.

257 laboratory-supported reactive non-treponemal serology (using the rapid plasma reagin [RPR] test).

258 Viral serology, viral load, and liver biochemistry were perfor

259 ve symptoms in patients with LB and positive serology was 0.71 (95% CI, .50-1.03) compared to patient

260 combination of HPV-positive DNA and E6 or E7 serology was associated with enhanced overall survival i

261 ures, 0.16; 95% CI, 0.03-0.46), whereas only serology was associated with outcome when considering al

262 In group 1, serology was available in 361 (33.8 %) patients.

263 CD specific serology was comparable to children with single CD, but

264 Positivity for H. pylori serology was higher in West Africa (P < 0.0001) and was

265 Serology was more often negative (14% vs 1%) and treatme

266 Standard agglutination serology was negative; the diagnosis was established by

267 Acute serology was nonreactive in all patients, though convale

268 Serology was not discriminative enough in identifying on

269 HTLV-1 serology was performed by Western blot on plasma samples

270 EBV serology was performed on EBV DNA-negative infants.

271 Trichinella species serology was performed on patient and family serum sampl

272 HIV serology was positive in 18.4% of participants, and hepa

273 rtRT-PCR was positive in 32 (8.9%) cases and serology was positive in 20 (10.8%) cases.

274 Serology was positive in 50 (98%) of the patients, and 1

275 Cytomegalovirus (CMV) serology was positive in 564 of 645 individuals (87%).

276 Coeliac disease serology was positive in all cases.

277 eactive in all patients, though convalescent serology was reactive in 6 of 8 (75%) patients for whom

278 ssments were done at baseline and 12 months; serology was tested at 18 months.

279 Mimivirus serology was tested by microimmunofluorescence and by bi

280 ned that the genetic basis for this aberrant serology was the presence of inactivating mutations in t

281 ype (P = 0.0008), but not positive H. pylori serology, was an independent predictor of plasma vitamin

282 Using multiplex serology, we determined the seroprevalence of 10 human P

283 Using genomics, histopathology, and serology, we found M. lepromatosis in squirrels from Eng

284 Using preseason and postseason serology, weekly illness reporting, and RT-PCR identific

285 revealed Bartonella quintana, and Bartonella serologies were subsequently noted to be positive.

286 In addition, HEV RNA and HEV serology were assessed pre- and post-alloHSCT.

287 Most pregnant women with discordant serology were CIA(+)/RPR(-)/TP-PA(-); more than half who

288 , specimens for blood and stool cultures and serology were collected from suspected cases.

289 th positive anti-hepatitis B surface antigen serology were excluded.

290 onegative patients with at least 1 follow-up serology were included.

291 Two of the 44 (5%) cases tested by serology were mumps IgM positive, and 27 of the 40 (68%)

292 of pathogens detected by conventional PCR or serology were not isolated by TGC-NGS, suggesting that f

293 cs, referral source, etiology, and hepatitis serology were recorded.

294 Blood culture and serology were used to detect HGA infection in patients w

295 anges in antibody to HBsAg levels, and donor serology, were not associated with HBV reactivation.

296 ) diagnostic sensitivity than current 2-tier serology, while retaining high specificity.

297 As this isolate expresses a unique serology with unique biochemistry and a stable genetic b

298 k of pandemic influenza A(H1N1) indicated by serology, with a vaccine efficacy estimate of 47% (95% C

299 nation of delayed (18)F-FDG PET and specific serology would prevent most of the recurrences observed

300 Serology yielded finding compatible with ZIKV as the cau